Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Baxter
Express Scripts
Mallinckrodt
McKesson

Last Updated: November 27, 2022

CLINICAL TRIALS PROFILE FOR LITHOBID


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Lithobid

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00183443 ↗ Treatment of Mania Symptoms With Drug Therapy Completed National Institute of Mental Health (NIMH) Phase 3 2005-02-01 This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00183443 ↗ Treatment of Mania Symptoms With Drug Therapy Completed Palo Alto Veterans Institute for Research Phase 3 2005-02-01 This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00408681 ↗ Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant Completed National Cancer Institute (NCI) N/A 2006-06-01 RATIONALE: Lithium carbonate may be an effective treatment for intestinal graft-versus-host disease caused by a donor stem cell transplant. PURPOSE: This clinical trial is studying lithium carbonate in treating patients with acute intestinal graft-versus-host-disease after donor stem cell transplant.
NCT00408681 ↗ Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant Completed Fred Hutchinson Cancer Research Center N/A 2006-06-01 RATIONALE: Lithium carbonate may be an effective treatment for intestinal graft-versus-host disease caused by a donor stem cell transplant. PURPOSE: This clinical trial is studying lithium carbonate in treating patients with acute intestinal graft-versus-host-disease after donor stem cell transplant.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lithobid

Condition Name

Condition Name for Lithobid
Intervention Trials
Bipolar Disorder 4
Recurrent Adult Acute Myeloid Leukemia 2
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities 2
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lithobid
Intervention Trials
Bipolar Disorder 5
Depressive Disorder 3
Depression 3
Leukemia, Myeloid, Acute 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lithobid

Trials by Country

Trials by Country for Lithobid
Location Trials
United States 19
Sweden 2
China 1
Canada 1
Norway 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lithobid
Location Trials
Ohio 2
New York 2
Michigan 2
Texas 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lithobid

Clinical Trial Phase

Clinical Trial Phase for Lithobid
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 2 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lithobid
Clinical Trial Phase Trials
Completed 9
Recruiting 2
Terminated 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lithobid

Sponsor Name

Sponsor Name for Lithobid
Sponsor Trials
National Institute of Mental Health (NIMH) 3
National Cancer Institute (NCI) 2
Columbia University 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lithobid
Sponsor Trials
Other 24
NIH 6
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Boehringer Ingelheim
McKinsey
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.